-
Je něco špatně v tomto záznamu ?
Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patients
V. Kuhrová, H. Francová, P. Zapletalová, T. Freiberger, L. Fajkusová, E. Hrabincová, R. Slováĉková, L. Kozák, R. Slováková,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu upravené články, časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-01-01 do 2007-12-31
Health & Medicine (ProQuest)
od 1997-01-01 do 2007-12-31
Wiley Online Library (archiv)
od 1996-01-01 do 2012-12-31
Public Health Database (ProQuest)
od 1997-01-01 do 2007-12-31
PubMed
11754108
DOI
10.1002/humu.9000
Knihovny.cz E-zdroje
- MeSH
- cholesterol krev MeSH
- DNA krev genetika MeSH
- dospělí MeSH
- heteroduplexní analýza MeSH
- hyperlipoproteinemie typ II krev epidemiologie genetika MeSH
- LDL-receptory genetika MeSH
- leukocyty chemie MeSH
- lidé MeSH
- mutace genetika MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- upravené články MeSH
- Geografické názvy
- Česká republika MeSH
The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in Czech hypercholesterolemic individuals. A combination of heteroduplex analysis, SSCP, DGGE, DNA sequencing and PCR/restriction analysis was used for this purpose. Molecular searching in the promoter region and coding sequence of the low density lipoprotein receptor (LDLR) gene in 130 patients from 68 unrelated families resulted in the identification of 37 sequence variations. Thirty of them are most likely disease causing mutations. Nineteen mutations were novel (two nonsense, five missense, six nucleotide(s) insertions and six nucleotide(s) deletions). Their pathological effect can be predicted on the basis of their position with respect to previously reported mutations with an estimated reduction of the receptor activity and/or premature termination of translation. These results expand our knowledge of mutations responsible for FH. Seven nucleotide variations were characterized as silent polymorphisms.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20013942
- 003
- CZ-PrNML
- 005
- 20200915104410.0
- 007
- ta
- 008
- 200911s2002 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/humu.9000 $2 doi
- 035 __
- $a (PubMed)11754108
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kuhrová, Viera $u Research Institute of Child Health, Department of Biochemical and Molecular Genetics, Cernopolní 9, CZ-662 62. vera.kuhrova@volny.cz
- 245 10
- $a Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patients / $c V. Kuhrová, H. Francová, P. Zapletalová, T. Freiberger, L. Fajkusová, E. Hrabincová, R. Slováĉková, L. Kozák, R. Slováková,
- 520 9_
- $a The aim of our study was to define mutations causing familial hypercholesterolemia (FH) phenotype in Czech hypercholesterolemic individuals. A combination of heteroduplex analysis, SSCP, DGGE, DNA sequencing and PCR/restriction analysis was used for this purpose. Molecular searching in the promoter region and coding sequence of the low density lipoprotein receptor (LDLR) gene in 130 patients from 68 unrelated families resulted in the identification of 37 sequence variations. Thirty of them are most likely disease causing mutations. Nineteen mutations were novel (two nonsense, five missense, six nucleotide(s) insertions and six nucleotide(s) deletions). Their pathological effect can be predicted on the basis of their position with respect to previously reported mutations with an estimated reduction of the receptor activity and/or premature termination of translation. These results expand our knowledge of mutations responsible for FH. Seven nucleotide variations were characterized as silent polymorphisms.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a cholesterol $x krev $7 D002784
- 650 _2
- $a DNA $x krev $x genetika $7 D004247
- 650 _2
- $a heteroduplexní analýza $7 D020180
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperlipoproteinemie typ II $x krev $x epidemiologie $x genetika $7 D006938
- 650 _2
- $a leukocyty $x chemie $7 D007962
- 650 _2
- $a mutace $x genetika $7 D009154
- 650 _2
- $a LDL-receptory $x genetika $7 D011973
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a upravené články $7 D016439
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Francová, Hana
- 700 1_
- $a Zapletalová, Petra
- 700 1_
- $a Freiberger, Tomás
- 700 1_
- $a Fajkusová, Lenka
- 700 1_
- $a Hrabincová, Eva
- 700 1_
- $a Slováĉková, Romana
- 700 1_
- $a Kozák, Libor
- 700 1_
- $a Slováková, Romana
- 773 0_
- $w MED00002078 $t Human mutation $x 1098-1004 $g Roč. 19, č. 1 (2002), s. 80
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/11754108 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200911 $b ABA008
- 991 __
- $a 20200915104406 $b ABA008
- 999 __
- $a ok $b bmc $g 1563386 $s 1104099
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2002 $b 19 $c 1 $d 80 $e - $i 1098-1004 $m Human mutation $n Hum Mutat $x MED00002078
- LZP __
- $a Pubmed-20200911